Concepedia

Matthias Glaser

MG

Statistics

Publications

39

Citations

2.2K

H-Index

25

Active since

1994

Affiliations

Hammersmith Hospital(Current)

Imperial College London

University College London

Freie Universität Berlin

Helmholtz-Zentrum Dresden-Rossendorf

Matthias Glaser is an author at Hammersmith Hospital specializing in medicine, molecular imaging, and positron emission tomography.

Publications per year

1994–2021

39

Publications

39

Phase I Trial of the Positron-Emitting Arg-Gly-Asp (RGD) Peptide Radioligand <sup>18</sup>F-AH111585 in Breast Cancer Patients

Laura Kenny, R. Charles Coombes, Inger Oulie et al. · Journal of Nuclear Medicine · 2008 · 277 citations · Full text

Medicine, Nuclear Medicine, Oncology +17

“Click Labeling” with 2-[<sup>18</sup>F]Fluoroethylazide for Positron Emission Tomography

Matthias Glaser, Erik Årstad · Bioconjugate Chemistry · 2007 · 206 citations

Natural Sciences, Chemistry, Medicinal Chemistry +13

Adenovirus Biodistribution and Noninvasive Imaging of Gene Expression <i>In Vivo</i> by Positron Emission Tomography Using Human Sodium/Iodide Symporter as Reporter Gene

Thomas Groot-Wassink, Eric O. Aboagye, Matthias Glaser et al. · Human Gene Therapy · 2002 · 165 citations

Medicine, Molecular Biology, Nuclear Medicine +17

Positron emission tomography imaging of drug-induced tumor apoptosis with a caspase-3/7 specific [ <sup>18</sup> F]-labeled isatin sulfonamide

Quang‐Dé Nguyen, Graham Smith, Matthias Glaser et al. · Proceedings of the National Academy of Sciences · 2009 · 165 citations · Full text

Medicine, Oncology, Pharmacology +17

Design, Synthesis, and Biological Characterization of a Caspase 3/7 Selective Isatin Labeled with 2-[<sup>18</sup>F]fluoroethylazide

Graham Smith, Matthias Glaser, Meg Perumal et al. · Journal of Medicinal Chemistry · 2008 · 131 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +17

1–5 of 39